Business
First ASX debut of 2021 off to a bang as TruScreen pops – Stockhead
Kiwi cervical cancer screening company TruScreen (ASX:TRU) has made a strong debut on the ASX and is now dual-listed. At 11.48 am, TRU shares were trading at 9c…
Link copied toclipboard
Kiwi cervical cancer screening company TruScreen (ASX:TRU) has made a strong debut on the ASX and is now dual-listed.
At 11.48 am, TRU shares were trading at 9c and earlier had reached as high as 9.9c, following a “compliance IPO” in which TruScreen raised about $1.9 million at NZ7c or 6.5c a share.
The company has been listed on the NZX since 2014 and its ASX listing brings back Australian medical technology to Australia.
TruScreen makes a pen-like digital wand that is placed…
-
General11 hours agoChina and Philippines trade blame over latest South China Sea clash
-
General12 hours agoSmall plane crashes into San Diego neighbourhood, setting homes and vehicles on fire
-
Noosa News21 hours agoConfusion over licensing and access to hunting grounds under WA’s strict gun laws
-
General11 hours agoOf saints and sinners | The Spectator Australia